Platelet Alloimmunization

Platelet Alloimmunization is a form of immune sensitization in which a recipient develops antibodies against human platelet antigens (HPAs) or human leukocyte antigens (HLAs) expressed on donor platelets following exposure through transfusion, pregnancy, or transplantation, leading to refractoriness to subsequent platelet transfusions.

343

Publications

16.6K

Citations

1.3K

Authors

414

Institutions

Publications per year

2017–2026

22

Variants

Platelet Allo-immunization

Authors

1.3K

  1. SS
    Sentot Santoso

    Justus-Liebig-Universität Gießen, Germany

    19 publications · 648 citations

    15

    h-index

  2. RH
    Richard H. Aster

    Versiti Blood Center of Wisconsin, United States

    13 publications · 1.6K citations

    13

    h-index

  3. WH
    Willem H. Ouwehand

    University of Cambridge, United Kingdom

    15 publications · 1K citations

    12

    h-index

  4. SJ
    Sherrill J. Slichter

    Bloodworks Northwest, United States

    11 publications · 444 citations

    11

    h-index

  5. CK
    C. Kaplan

    Institut National de la Transfusion Sanguine, France

    11 publications · 298 citations

    11

    h-index

1–5 of 1.3K

Venues

  1. Blood

    52 publications · 4K citations

    38

    h-index

  2. Transfusion

    69 publications · 2.9K citations

    31

    h-index

  3. British Journal of Haematology

    BJH · 34 publications · 2K citations

    25

    h-index

  4. Vox Sanguinis

    37 publications · 2K citations

    21

    h-index

  5. Transfusion Medicine

    23 publications · 743 citations

    15

    h-index

1–5